Let’s get better!
Experts in pharma
Experts in nutra
Better delivery.
Health products are only as good as how well they’re delivered to the body.
explore capsules
Better manufacturing.
Health products are only as good as the equipment
that makes them.
explore machinery
Better protection.
Health products are only as good as the barriers
that protect their integrity.
explore packaging materials
Book a Meeting
Welcome to ACG
With a presence in 138 countries on six continents, ACG is now the world’s largest integrated supplier and service provider to solid dosage manufacturers –providing hard shell capsules, barrier packaging solutions, track and trace systems, and process, packing and vision inspection equipment.
We make it better, so you can make it better, and together we can make people better.
Integrated solutions
Uniquely involved in all aspects of solid dosage production, only ACG can offer holistic manufacturing advice and solutions. Things work better when they’re designed to work together, and having fewer suppliers also means simpler accountability if things go wrong.
Products
ACG touches almost every aspect of oral dosage manufacturing. Our holistic view is based on a belief that this is the best approach to enabling seamless production alongside fully accountable service.
ACG in numbers
130 billion
Capsules we can produce annually
23,947
Machines we’ve installed for customers
138
Countries we serve across six continents
63
Years’ pharmaceutical experience
1
Goal to make the world healthier, together
Latest news
NBJ Global Markets Overview - Q&A with Rafael Costa
NBJ Nutrition Business JournalLeading sales across North and South America for the mammoth contract manufacturer ACG, Rafael Costa keeps his feet on the ground in two hemispheres and a wide range of markets faced with a wide range of economic conditions and regulatory systems. We asked him for his quick thoughts on what he sees going on for supplements, looking south from the U.S.
Read more
2023 pharma predictions
Pharma manufacturingThe pandemic continued to affect supply chains, inflation was at a recent all-time high, and FDA approvals hit a five-year low. The Inflation Reduction Act was signed into law back in August, promising to limit the pharma industry’s pricing power.
Read more
Looking into the OSD Crystal Ball: Industry Experts Reflect on Opportunities & Challenges in '23 & Beyond
Tablets & CapsulesThe Future of Quality in ManufacturingThe next decade will see pharmaceutical companies change their manufacturing ecosystems with emphasis on product quality, speed to market, efficiency, waste reduction, cost containment and skill retention to meet regulatory and consumer demands.
Read more
You can’t have healthy people without a healthy planet.
